Study title:
Moens M, Van Meensel A, Willems W, Schuermans V, Cauwenbergh G. Combined analyses of adverse experiences and clinical laboratory data related to safety in patients treated with itraconazole for vulvovaginal candidosis, pityriasis versicolor, dermatomycoses, oral candidosis and fungal keratitis. Clinical research report on R051211 no-87, September 1987. (<15->65 years, LMD56766).Moens M, Van Meensel A, Willems W, Schuermans V, Cauwenbergh G. Combined analyses of adverse experiences and clinical laboratory data related to safety in patients treated with itraconazole for vulvovaginal candidosis, pityriasis versicolor, dermatomycoses, oral candidosis and fungal keratitis. Clinical research report on R051211 no-87, September 1987. (<15->65 years, LMD56766).
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Bacterial Infections and Mycoses [C01]
|
Brands: Please see report, Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: ITRACONAZOLE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
-
|
Y
|